Thiakis: Gut check

Obesity has resisted most attempts at therapeutic intervention, but Thiakis Ltd. has rights to two endogenous gut peptides, oxyntomodulin and peptide YY3-36, that it hopes will be more successful. According to the company, the endogenous OXM gut hormone caused more weight loss in one 28-day study than any other agent tested to date.

"Thiakis was founded on the basis of the work of Steve Bloom at Imperial College London," said CEO

Read the full 713 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE